Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V E Jones

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Postgraduate Medical Journal|January 1, 1976
Toleracne to equine IgG after immunosuppression in patients with multiple sclerosisV E Jones, E M Lance, J Abbosh, et al.
Clinical and Experimental Immunology|July 1, 1982
Immune complexes in early arthritis. II. Immune complex constituents are synthesized in the synovium before rheumatoid factorsV E Jones, R K Jacoby, P J Cowley, et al.
Gut|May 1, 1979
Effect of ouabain on Na,K-ATPase and electrolyte transport in the dog ileum in vivoN W Read, G J Krejs, V E Jones, et al.
Annals of the Rheumatic Diseases|August 1, 1978
Intra-articular methotrexate. Clinical and laboratory study in rheumatoid and psoriatic arthritisG H Hall, B J Jones, A C Head, et al.
Arthritis and Rheumatism|June 1, 1986
Rheumatoid arthritis: clinical onset, seropositivity, and a possible causeV E Jones, R K Jacoby, A H Puttick, et al.
Clinical and Experimental Immunology|March 1, 1988
A new assay uses monoclonal anti-Rh(D) antibodies to determine rheumatoid factor specificity: reactivity to a monoclonal antibody of the Gm allotype G3m(21) is more frequent in rheumatoid patients negative for G3m(21)V E Jones, A H Puttick, E A Williamson, et al.
Cellular Immunology|April 1, 1989
Antiproliferative mechanism of anti-class II monoclonal antibodiesL Vaickus, V E Jones, C L Morton, et al.
The Journal of Biological Chemistry|January 21, 1994
Species-specific changes in regulatory elements of mouse haptoglobin genesS Pajovic, V E Jones, K R Prowse, et al.
Clinical and Experimental Immunology|July 1, 1975
Intensive immunosuppression in patients with disseminated sclerosis. I. Clinical responseE M Lance, M Kremer, J Abbosh, et al.
Clinical and Experimental Immunology|June 1, 1982
The complement fixing properties and class distribution of rheumatoid factors (antiglobulins) in rheumatoid arthritis and other diseasesR E March, J S Reeback, E J Holborow, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Postgraduate Medical Journal|January 1, 1976
Toleracne to equine IgG after immunosuppression in patients with multiple sclerosisV E Jones, E M Lance, J Abbosh, et al.
Clinical and Experimental Immunology|July 1, 1982
Immune complexes in early arthritis. II. Immune complex constituents are synthesized in the synovium before rheumatoid factorsV E Jones, R K Jacoby, P J Cowley, et al.
Gut|May 1, 1979
Effect of ouabain on Na,K-ATPase and electrolyte transport in the dog ileum in vivoN W Read, G J Krejs, V E Jones, et al.
Annals of the Rheumatic Diseases|August 1, 1978
Intra-articular methotrexate. Clinical and laboratory study in rheumatoid and psoriatic arthritisG H Hall, B J Jones, A C Head, et al.
Arthritis and Rheumatism|June 1, 1986
Rheumatoid arthritis: clinical onset, seropositivity, and a possible causeV E Jones, R K Jacoby, A H Puttick, et al.
Clinical and Experimental Immunology|March 1, 1988
A new assay uses monoclonal anti-Rh(D) antibodies to determine rheumatoid factor specificity: reactivity to a monoclonal antibody of the Gm allotype G3m(21) is more frequent in rheumatoid patients negative for G3m(21)V E Jones, A H Puttick, E A Williamson, et al.
Cellular Immunology|April 1, 1989
Antiproliferative mechanism of anti-class II monoclonal antibodiesL Vaickus, V E Jones, C L Morton, et al.
The Journal of Biological Chemistry|January 21, 1994
Species-specific changes in regulatory elements of mouse haptoglobin genesS Pajovic, V E Jones, K R Prowse, et al.
Clinical and Experimental Immunology|July 1, 1975
Intensive immunosuppression in patients with disseminated sclerosis. I. Clinical responseE M Lance, M Kremer, J Abbosh, et al.
Clinical and Experimental Immunology|June 1, 1982
The complement fixing properties and class distribution of rheumatoid factors (antiglobulins) in rheumatoid arthritis and other diseasesR E March, J S Reeback, E J Holborow, et al.
Pageof 5